全文获取类型
收费全文 | 2370009篇 |
免费 | 199358篇 |
国内免费 | 5112篇 |
专业分类
耳鼻咽喉 | 34343篇 |
儿科学 | 72668篇 |
妇产科学 | 63045篇 |
基础医学 | 333525篇 |
口腔科学 | 67720篇 |
临床医学 | 216006篇 |
内科学 | 466058篇 |
皮肤病学 | 48017篇 |
神经病学 | 199860篇 |
特种医学 | 96298篇 |
外国民族医学 | 897篇 |
外科学 | 360494篇 |
综合类 | 58683篇 |
现状与发展 | 4篇 |
一般理论 | 978篇 |
预防医学 | 190098篇 |
眼科学 | 55756篇 |
药学 | 178410篇 |
20篇 | |
中国医学 | 5078篇 |
肿瘤学 | 126521篇 |
出版年
2018年 | 24656篇 |
2017年 | 19218篇 |
2016年 | 20946篇 |
2015年 | 23857篇 |
2014年 | 34245篇 |
2013年 | 51468篇 |
2012年 | 69773篇 |
2011年 | 73421篇 |
2010年 | 43277篇 |
2009年 | 41539篇 |
2008年 | 69445篇 |
2007年 | 73867篇 |
2006年 | 74700篇 |
2005年 | 72712篇 |
2004年 | 69750篇 |
2003年 | 67259篇 |
2002年 | 66450篇 |
2001年 | 112558篇 |
2000年 | 116493篇 |
1999年 | 97952篇 |
1998年 | 26392篇 |
1997年 | 23969篇 |
1996年 | 23875篇 |
1995年 | 24571篇 |
1994年 | 23124篇 |
1993年 | 21494篇 |
1992年 | 79332篇 |
1991年 | 76442篇 |
1990年 | 73593篇 |
1989年 | 70845篇 |
1988年 | 65817篇 |
1987年 | 64788篇 |
1986年 | 61319篇 |
1985年 | 58386篇 |
1984年 | 44159篇 |
1983年 | 37550篇 |
1982年 | 22803篇 |
1981年 | 20234篇 |
1979年 | 41227篇 |
1978年 | 28911篇 |
1977年 | 24246篇 |
1976年 | 22756篇 |
1975年 | 23906篇 |
1974年 | 29590篇 |
1973年 | 28011篇 |
1972年 | 26208篇 |
1971年 | 24143篇 |
1970年 | 22729篇 |
1969年 | 21070篇 |
1968年 | 19118篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
51.
Rajiv V. Dave Baek Kim Alona Courtney Rachel OConnell Tim Rattay Vicky P. Taxiarchi Jamie J. Kirkham Elizabeth M. Camacho Patricia Fairbrother Nisha Sharma Christopher W. J. Cartlidge Kieran Horgan Stuart A. McIntosh Daniel R. Leff Raghavan Vidya Shelley Potter Chris Holcombe Ellen Copson Charlotte E. Coles Ramsey I. Cutress Ashu Gandhi Cliona C. Kirwan 《British journal of cancer》2021,124(11):1785
Background The B-MaP-C study aimed to determine alterations to breast cancer (BC) management during the peak transmission period of the UK COVID-19 pandemic and the potential impact of these treatment decisions.Methods This was a national cohort study of patients with early BC undergoing multidisciplinary team (MDT)-guided treatment recommendations during the pandemic, designated ‘standard’ or ‘COVID-altered’, in the preoperative, operative and post-operative setting.Findings Of 3776 patients (from 64 UK units) in the study, 2246 (59%) had ‘COVID-altered’ management. ‘Bridging’ endocrine therapy was used (n = 951) where theatre capacity was reduced. There was increasing access to COVID-19 low-risk theatres during the study period (59%). In line with national guidance, immediate breast reconstruction was avoided (n = 299). Where adjuvant chemotherapy was omitted (n = 81), the median benefit was only 3% (IQR 2–9%) using ‘NHS Predict’. There was the rapid adoption of new evidence-based hypofractionated radiotherapy (n = 781, from 46 units). Only 14 patients (1%) tested positive for SARS-CoV-2 during their treatment journey.Conclusions The majority of ‘COVID-altered’ management decisions were largely in line with pre-COVID evidence-based guidelines, implying that breast cancer survival outcomes are unlikely to be negatively impacted by the pandemic. However, in this study, the potential impact of delays to BC presentation or diagnosis remains unknown.Subject terms: Breast cancer, Surgical oncology, Health care economics, Quality of life, Health policy 相似文献
52.
J. Barnett I. Pulzato M. Javed Y.J. Lee A. Choraria S.V. Kemp A. Rice S. Jordan P.L. Shah A.G. Nicholson S. Padley A. Devaraj 《Clinical radiology》2021,76(1):77.e9-77.e15
53.
The COVID-19 pandemic and the consequent declaration of a state of alarm have required changes throughout the entire health system and diagnostic imaging departments are no exception.In our department, these circumstances led to an immediate restructuring of the working dynamics of our group of imaging technologists that had an important role in the front lines of the battle. To ensure that these new needs were met, the staff had to be trained and distributed into different areas and working groups; moreover, new protective measures and protocols had to be adopted in the working environment. We also defined different care circuits for patients with COVID-19 and those without COVID-19, incorporating new technologies, adapting existing resources to the new scenario, and creating a circuit for the rapid diagnosis of COVID-19. This paper also provides detailed recommendations for organizing radiology departments in the case of new outbreaks of COVID-19. 相似文献
54.
L.S. Becker S.K. Maschke C.L.A. Dewald T.C. Meine H.B.M. Winther M.M. Kirstein R. Kloeckner B.C. Meyer F. Wacker J.B. Hinrichs 《Clinical radiology》2021,76(2):160.e27-160.e33
55.
Arguably, the two most important causes of pathological healing in the skin are diabetes and ageing. While these factors have historically been considered independent modifiers of the healing process, recent studies suggest that they may be mechanistically linked. The primary contributor to diabetic pathology is hyperglycaemia, which accelerates the production of advanced glycation end products, a characteristic of ageing tissue. Indeed, advanced age also leads to mild hyperglycaemia. Here, we discuss emerging literature that reveals a hitherto unappreciated link between cellular senescence, diabetes and wound repair. Senescent cells cause widespread destruction of normal tissue architecture in ageing and have been shown to be increased in chronic wounds. However, the role of senescence remains controversial, with several studies reporting beneficial effects for transiently induced senescence in wound healing. We recently highlighted a direct role for senescence in diabetic healing pathology, mediated by the senescence receptor, CXCR2. These findings suggest that targeting local tissue senescence may provide a therapeutic strategy applicable to a broad range of chronic wound types. 相似文献
56.
57.
58.
Praerna H. Bhargav Preethi V. Reddy Ramajayam Govindaraj Kankan Gulati Arya Ravindran D. Gayathri Sneha J. Karmani Kaviraja Udupa Ganesan Venkatasubramanian Mariamma Philip Monojit Debnath Rose Dawn Bharath T. N. Sathyaprabha Bangalore N. Gangadhar Kesavan Muralidharan 《Revue canadienne de psychiatrie》2021,66(2):179
59.